AZN vs LLY
AstraZeneca PLC · Eli Lilly and Company
Relative return (rebased to 100)
Key stats
| Metric | AZN | LLY |
|---|---|---|
| Price | $186.65 | $1,417.54 |
| Market Cap | $289.31B | $1.33T |
| P/E | 28.29 | 64.61 |
| P/B | 5.94 | 33.11 |
| P/S | 4.93 | 20.46 |
| ROE | 21.0% | 51.3% |
| Net Margin | 17.4% | 31.7% |
| Gross Margin | 81.9% | — |
| Revenue Growth | 8.6% | 44.7% |
| Dividend Yield | 1.68% | 0.44% |
| EPS | $6.60 | $21.94 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.